Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCT

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

84 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-10

Study Completion Date

2019-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To Evaluate and compare the outcome and coast of ejaculation sparing management of BPH using 3 different techniques: PVP, PKVP and TURP. Ejaculation sparing TURP group is considered the standard control group. Evaluation will be carried out through a prospective randomized powered trial

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

High Power Thulium Vaporization vs Transurethral Resection of the Prostate for Treatment of BPH

NCT03264482

Benign Prostatic Hyperplasia

COMPLETED NA

Bipolar Resection vs Enucleation of Prostate

NCT06983444

Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection Benign Prostatic Hyperplasia With Outflow Obstruction Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms +1 more

RECRUITING NA

Laser Vaporization of the Prostate: Comparing Between Ejaculatory Preserving and Non-ejaculatory Preserving Technique

NCT06091618

Prostatic Hyperplasia

UNKNOWN NA

Bipolar Needlescopic Enucleation Versus Vapoenucleation of BPH

NCT04331301

Prostate Obstruction Prostatic Hyperplasia Prostatic Hypertrophy, Benign

COMPLETED NA

Outcomes and Efficacy of Ejaculatory Preserving Transurethral Resection of Prostate

NCT05914519

Ejaculatory Dysfunction BPH

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ejaculation Abnormal BPH With Urinary Obstruction Prostatic Hyperplasia Prostate Disease Prostate Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Photoselective Vaporization

Group Type ACTIVE_COMPARATOR

Ejaculation Preserving Photoselective Vaporization

Intervention Type PROCEDURE

Ejaculation Preserving Photoselective Vaporization

Plasma Kinetic Vaporization

Group Type ACTIVE_COMPARATOR

Ejaculation Preserving Plasma Kinetic Vaporization

Intervention Type PROCEDURE

Ejaculation Preserving Plasma Kinetic Vaporization

Transurethral Resection Of The Prostate

Group Type ACTIVE_COMPARATOR

Ejaculation Preserving Transurethral Resection Of The Prostate

Intervention Type PROCEDURE

Ejaculation Preserving Transurethral Resection Of The Prostate

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ejaculation Preserving Photoselective Vaporization

Intervention Type PROCEDURE

Ejaculation Preserving Plasma Kinetic Vaporization

Intervention Type PROCEDURE

Ejaculation Preserving Transurethral Resection Of The Prostate

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. Age \>50 years 2. Prostate volume (measured by TRUS): 30-80 gm 3. International prostate symptom score (IPSS )\>15 and quality of life score (QOL)\< 3.

4\. Maximum flow rate of uroflometry \<10 ml/second 5. Patients with active sexual life (or interested) and having the ability to ejaculate and desire to preserve ejaculation.

6\. Failure or intolerance to medical treatment, recurrent urinary infection, urine retention, significant hematuria or deterioration of the upper urinary tract function secondary to BOO.

Exclusion Criteria

1. Bleeding disorders and patients on anticoagulant treatment
2. Histologically proved cancer prostate
3. Neurogenic voiding dysfunction
4. Lower urinary tract malignancy
5. Preoperative ejaculation or sexual dysfunction
6. Presence of stricture urethra
7. Unfit for spinal anathesia -

Minimum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes